CCPA Compliance Risks in Surgical Device Companies
As the surgical device industry continues its rapid shift toward connected, data-driven products and services, many companies find themselves discussing cybersecurity (pun intended) from three overlapping perspectives. Is our organization prepared for the FDA’s cybersecurity guidance? Are there gaps in device-level security? And just as importantly, how can we stay ahead of cybersecurity risk as it continues to evolve?
While these areas remain top of mind, another regulatory and legal framework is quietly expanding the definition of risk: CCPA.
The California Consumer Privacy Act (CCPA) represents a significant shift in how consumer data is protected in the United States. Surgical device companies, especially those developing connected devices, AI-enabled tools, or companion applications, should take note.
How CCPA Expands the Medical Device Attack Surface
A connected medical device introduces unique risks to patient safety through its integration with hospital IT environments, cloud services, and analytics platforms. The FDA has repeatedly emphasized that cybersecurity vulnerabilities in medical devices can impact both safety and effectiveness.
But what if we broaden the definition of “attack surface”? What happens when we consider not just the device, but the data it collects?
- Patient information
- Usage statistics
- Behavioral analytics
- Identifiable biosignatures
Under CCPA, this data may qualify as “personal information,” defined broadly as:
“Information that identifies, relates to, describes, is capable of being associated with, or could reasonably be linked…with a particular consumer or household.” – CCPA statutory definition
HIPAA vs CCPA: Where Risk Still Exists
Patients Are Consumers, Too
CCPA establishes that consumers have rights over their personal information, including access, deletion, and opt-out rights. Patients, particularly those interacting with connected devices or digital health tools, fall within this scope.
While HIPAA provides exemptions for certain protected health information (PHI), those exemptions are limited and do not cover all data flows.
AI, Connected Devices, and Privacy Risk
Where CCPA “Hits” the Surgical Device Ecosystem
Many healthcare organizations assume CCPA does not apply due to HIPAA. However, that assumption creates risk.
CCPA can apply to:
- Device-generated data outside clinical records
- Companion apps and patient portals
- Consumer marketing platforms
- Employee and contractor data tied to device operations
The result is a fragmented compliance landscape across product development, commercialization, and post-market risk management.
Research shows healthcare organizations already face:
- Unclear regulatory scope
- Difficulty locating personal data
- Rising compliance costs
Webinar A Practical Guide to Governing Native AI, Browser-Based AI, and Third-Party AI Tools
Legal, Financial, and Brand Impacts of Non-Compliance
Adding “Privacy Risk” to Clinical Risk Management
Historically, medical device risk frameworks focused on safety, performance, and cybersecurity. CCPA expands that responsibility into privacy risk.
Recent updates under the California Privacy Rights Act (CPRA), which amends CCPA, introduce requirements such as:
- Risk assessments for high-risk data processing
- Cybersecurity audits
- Consumer rights related to automated decision-making
How Surgical Device Companies Can Reduce CCPA Risk
For surgical device companies leveraging AI, such as imaging, robotics, or decision support, this introduces a new expectation: Trust is no longer just about safety and efficacy; it’s about data transparency and control.
Accurate Algorithms Are Not Enough
Medical device companies already face challenges explaining complex algorithms. Under CCPA/CPRA, they may also need to explain:
- How an algorithm works
- Why was it used
- What data informed its output
This reflects a broader regulatory trend toward algorithmic transparency and accountability, as in FTC guidance on AI transparency.
The Hidden Risk: The Ecosystem Around the Device
Risk is not limited to the device itself. Consider:
- Remote monitoring dashboards
- Mobile apps
- Cloud analytics platforms
- Hospital system integrations
These components may fall outside FDA oversight but remain subject to privacy laws like CCPA.
The Impact of Non-Compliance: Brand Risk & Litigation
CCPA includes a private right of action for certain data breaches involving unencrypted personal information. (California Civil Code 1798.150)
Organizations may face:
- Regulatory enforcement by the California Attorney General
- Class action lawsuits
- Financial penalties and reputational damage
Recent years have already seen increasing CCPA-related litigation shaping expectations for data protection practices. For surgical device companies, the stakes extend further:
- Patient trust
- Provider relationships
- Brand credibility
Cybersecurity Isn’t Just About Security Anymore
Cybersecurity in medical devices has already evolved with FDA guidance emphasizing lifecycle risk management. CCPA signals the next phase of that evolution.
For surgical device companies, success will depend on how well they navigate this intersection of innovation, regulation, and accountability.
Review Your CCPA Privacy Risk Posture
Read more AI (Artificial Intelligence) Risk Insights and
Review Your AI Security and Risk Posture
Review Your CoPilot Security Position
